IX BIOPHARMA LTD.
Registration and award facts
SAM.gov registration as of
- Net obligations since FY2026
- $7.13M
- $7,127,731under this UEI
- FY2026 obligations
- $7.13M†
- $7,127,731Provisional
- Awards and orders
- 1
- with positive net obligations
- Latest action
- Feb 5, 2026
- SAM.gov registration
- Active
- Registration expiration date Feb 23, 2027
Registration
- Business start date
- May 8, 2004 (22 years)
- Location
- Singapore
† FY2026 obligations (provisional; DoD awards signed after Jul 29, 2026 are not yet public).
Contract actions that the Department of Defense both funds and awards are withheld at the source for 90 days, so DoD awards signed after Jul 29, 2026 are not yet public.
Source: SAM.gov entity registration and FPDS contract actions recorded under UEI UJ73DZNC8HW4. GovChime does not check exclusions.
Performance
Net obligations recorded under this UEI since FY2026. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.
Net obligations by fiscal year of action
- FY2026: $7,127,731 (provisional)
Total across 1 fiscal year: $7,127,731
Top awarding agencies
- Department of Defense$7,127,731, 100%
Top awarding sub-agencies
- Defense Health Agency$7,127,731, 100%
Top product and service codes by obligations
- AN13Health r&d services; health care services; experimental development$7,127,731, 100%
Capabilities
SBA certifications
No certification in the SBA profile data.
Contracts
Latest awards and orders
- HT9427269E001Other transaction agreementDepartment of DefenseDefense Health AgencyLatest action
Contact Info
As of . Source: SAM.gov Points of Contact.
SAM.gov registration for IX BIOPHARMA LTD. lists a physical address, along with 2 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.
Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).
Physical Address
SINGAPORE, N/A, 049319
Government Business Contact
EVA TAN
CHIEF COMMERCIAL OFFICER
Electronic Business Contact
EVA TAN
CHIEF COMMERCIAL OFFICER
Additional Details
As of . Source: SAM.gov Entity Registration.
IX BIOPHARMA LTD. has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires February 23, 2027.
Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.
Compliance & Risk Assessment
Source: SAM.gov FAR responsesSuspension/Debarment Status
SAM.gov registration reports no active exclusion
Public Display
Entity information is publicly displayed
Registration Details
Source: SAM.govInitial Registration
Last Update
Registration Activation
Fiscal Year End
Country of Incorporation